Supplement shows promise for diabetes blood flow issues

NCT ID NCT04557228

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested whether a dietary supplement called phosphatidylserine can improve blood flow in people with type 2 diabetes. 36 adults took either the supplement or a placebo for 4 weeks. Researchers measured blood flow in the leg and arm to see if the supplement helped blood vessels work better.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
phosphatidylserine (a dietary supplement)
What this could lead to
If it works, this could point toward a simple dietary supplement to improve blood vessel function in people with type 2 diabetes.
What could go wrong
This was a small, early-stage trial with only 36 participants. The supplement may not show meaningful benefits, and results may not apply to everyone with diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Missouri- NextGen Clinical Translational Science Unit

    Columbia, Missouri, 65212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.